EUSA Pharma
Rick Baker has a diverse work experience in the pharmaceutical industry. Rick has worked as a Division Sales Manager for BeiGene since 2019. Prior to that, they were a Regional Business Director at EUSA Pharma in 2018 and at La Jolla Pharmaceutical Company in 2017. From 2015 to 2017, Rick was a District Sales Manager at Amgen. Rick also worked as a Senior oncology specialist at Onyx Pharmaceuticals from 2012 to 2015. In 2011, they were a Hematology Oncology Consultant at Celgene. Before that, they served as a Western Business Manager at Actelion Pharmaceutical from 2006 to 2011. Rick also held positions as a Cardiovascular Consultant at Scios from 2005 to 2006 and as a Cardiovascular Specialty Representative at Pfizer from 2000 to 2005.
Rick Baker attended California State University-Sacramento from 1993 to 1995 and obtained a Bachelor's degree. The field of study is unknown.
This person is not in any offices
EUSA Pharma
1 followers
We are committed to transforming the lives of people affected by cancer or rare disease, globally. We continuously strive to uncover opportunities which address gaps across adult and paediatric care. Helping the people with few or no options available is at the heart of everything we do. EUSA Pharma is part of Recordati Rare Diseases (recordatirarediseases.com), the business unit dedicated to rare disease in the Recordati group. Recordati has a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. More information can be found in the press release: https://www.recordati.com/resources/Pubblicazione/___58a6bc05f57c4861aae203c930cd1682_/eusa-closing-pr.pdf We see a need. We work together. We don’t give up.